Cardiac Researchers at National Heart Centre Singapore Acquire First SyncroPatch 384/768PE in Asia
Scientific Director Dr. Winston Shim and his research group aim at restoring compromised heart tissue by using stem cell…
Scientific Director Dr. Winston Shim and his research group aim at restoring compromised heart tissue by using stem cell…
Nanion’s automated patch clamp platforms are known for their high cell compatibility, even for primary cells and stem ce…
Nanion Technologies is one of the leading providers of high quality automated patch clamp systems. Nanion's efficient an…
10 years ago, Nanion Technologies started out in a small loft at the Institute of Physiology of Ludwig-Maximilian’s Univ…
The new year has started well for Nanion; in the first weeks of 2011 more than five Patchliners were sold and shipped to…
Der deutsche Gründerpreis ist die bedeutendste Auszeichnung für herausragende Unternehmer in Deutschland und zeichnet un…
The Deutscher Gründerpreis is the most important award for outstanding entrepreneurs in Germany and recognizes entrepren…
Kardiomyozyten aus embryonalen Stammzellen (ES) haben ein außerordentliches Potential im Bereich der kardialen Sicherhei…
Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an…
The SyncroPatch 96, a high quality, high throughput patch clamp ion channel screening platform, shows impressive results…